Biomarkers and biomarker validation: a pathologist's guide to getting it right

Area of Science:

• Biomarker discovery and development
• Translational research
• Clinical diagnostics

Background:

• Biomarkers are crucial for personalized medicine, enhancing diagnosis, prognosis, and treatment response prediction.
• The journey of a biomarker from discovery to clinical use involves complex scientific, clinical, and regulatory validation.
• Pathologists are key in ordering and interpreting biomarker assays, necessitating a deep understanding of their development.

Purpose of the Study:

• To provide an overview of biomarker development, approval, and validation processes.
• To equip anatomical pathologists with knowledge for effective biomarker testing in routine practice.
• To highlight potential pitfalls in biomarker implementation that could lead to inaccurate results.

Main Methods:

• Review of biomarker development lifecycle
• Analysis of validation and approval pathways
• Discussion of regulatory considerations across jurisdictions

Main Results:

• Biomarker development is a multi-stage process requiring rigorous validation.
• Regulatory approval pathways vary significantly by region.
• Successful implementation depends on understanding potential testing inaccuracies.

Conclusions:

• Pathologists require comprehensive knowledge of biomarker development and validation for accurate clinical application.
• Understanding the complexities of biomarker approval is essential for integrating new tests into practice.
• Addressing implementation challenges ensures reliable biomarker testing in personalized medicine.